Search | IOVS | ARVO Journals

View

Showing 1 – 14 of 14

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract April 2011

Effect of Intravitreal Bevacizumab (Avastin®) on Retinal Blood Vessel Diameter in the Injected and Contralateral Eye in a Diverse Clinic Population

Teddy Lyu; Diane Chang; Khurram Chaudhary; Ronni M. Lieberman; Robert M. Fischer

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1699. doi: https://doi.org/

ARVO Annual Meeting Abstract April 2010

Effect of Intravitreal Bevacizumab (Avastin®) on the Area of the Foveal Avascular Zone in the Injected and Contralateral Eye in a Diverse Clinic Population

N. Sun; C. J. Patel; R. M. Lieberman; R. M. Fischer

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):3578. doi: https://doi.org/

ARVO Annual Meeting Abstract April 2010

A Two-Year Analysis Evaluating the Treatment of Diabetic Macular Edema With Intravitreal Triamcinolone, Focal-Grid Laser, or Combination Therapy in an Underserved Population

C. J. Patel; N. Sun; R. M. Lieberman; R. M. Fischer

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):4226. doi: https://doi.org/

ARVO Annual Meeting Abstract April 2009

Treatment Comparison of Intravitreal Bevacizumab (Avastin®), Focal-grid Laser and Combination Therapy for Diabetic Macular Edema in a Diverse Clinic Population

C. C. Zatezalo; K. E. Burleigh; R. M. Lieberman; R. M. Fischer

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):185. doi: https://doi.org/

ARVO Annual Meeting Abstract April 2009

Treatment of Diabetic Macular Edema With Intravitreal Triamcinolone, Focal-grid Laser or Combination Therapy in a Diverse Clinic Population

K. E. Burleigh; C. C. Zatezalo; R. M. Lieberman; R. M. Fischer

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):190. doi: https://doi.org/

ARVO Annual Meeting Abstract April 2009

A Comparison of Microperimetry Using the Spectral OCT/SLO With Humphrey Field Analysis

S. E. Brown; S. E. Brodie; R. M. Fischer

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5291. doi: https://doi.org/

ARVO Annual Meeting Abstract May 2008

A Comparison of Presentation and Outcome in Immunocompetent and Immunocompromised Patients With Posterior Uveitis Secondary to Toxoplasmosis in an Indigent Patient Population

A. A. Macedo; S. Hsieh; D. Chruscicki; R. M. Lieberman; R. M. Fischer

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5128. doi: https://doi.org/

ARVO Annual Meeting Abstract May 2008

Long Term Visual Outcomes in Patients Receiving Intravitreal Bevacizumab (Avastin)

R. Radhakrishnan; C. Zatezalo; F. Esmail; R. M. Lieberman; R. M. Fischer

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5583. doi: https://doi.org/

ARVO Annual Meeting Abstract May 2008

The Effect of Intravitreal Bevacizumab (Avastin®) on Systemic Blood Pressure

F. Q. Esmail; R. Radhakrishnan; R. M. Lieberman; R. M. Fischer

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5614. doi: https://doi.org/

ARVO Annual Meeting Abstract May 2008

Outcomes in Eyes Treated With Intravitreal Bevacizumab (Avastin® ) and Panretinal Photocoagulation for Neovascular Glaucoma in a Diverse Clinic Population

K. J. Zamecki; R. M. Fischer; R. M. Lieberman

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1224. doi: https://doi.org/

ARVO Annual Meeting Abstract May 2007

The Use of Ovine Hyaluronidase (Vitrase®) in Non-Clearing Vitreous Hemorrhage of Varying Durations

D. A. Chruscicki; S. Hsieh; A. G. Nagpal; A. Toor; R. Radhakrishnan; N. N. Vaidya; S. Oh; R. M. Lieberman; R. M. Fischer

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1399. doi: https://doi.org/

ARVO Annual Meeting Abstract May 2007

Intravitreal Bevacizumab as an Adjunct to Ovine Hyaluronidase (Vitrase®) in the Long-Term Management of Vitreous Hemorrhage

A. Toor; D. Chruscicki; A. Macedo; R. L. Lieberman; R. M. Fischer

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):265. doi: https://doi.org/

ARVO Annual Meeting Abstract May 2007

Severity and Duration of Uveitis as a Prognostic Factor in Patients With Cytomegalovirus Retinitis (CMVR) and Immune Reconstitution Uveitis (IRU)

A. Nagpal; N. N. Vaidya; R. M. Lieberman; D. A. Chruscicki; R. M. Fischer

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):339. doi: https://doi.org/

ARVO Annual Meeting Abstract May 2007

Long-Term Follow-Up of HIV-Positive Patients With Infectious Posterior Ophthalmic Disease in a City Hospital Population

S. Hsieh; R. M. Lieberman; D. A. Chruscicki; A. Toor; N. N. Vaidya; S. R. Oh; K. J. Zamecki; R. M. Fischer

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):340. doi: https://doi.org/

Advertisement